Brief: Tcr² Therapeutics Reports Q2 Loss Per Share Of $0.67

TCR2 Therapeutics

12/08/2020 11:57

Aug 12 (Reuters) - TCR2 Therapeutics Inc  TCRR.O :
    * TCR² THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * RAISED GROSS PROCEEDS OF $142.6 MILLION IN A SECONDARY
OFFERING
IN JULY; EXTENDED CASH RUNWAY INTO 2023
    * QTRLY LOSS PER SHARE $0.67
    * Q2 EARNINGS PER SHARE VIEW $-0.65 -- REFINITIV IBES DATA
    * CONTINUES TO PROJECT NET CASH USE OF $60-70 MILLION FOR
2020

Source text for Eikon:  ID:nGNX7xRjRk 
Further company coverage:  TCRR.O 

 ((Reuters.Briefs@thomsonreuters.com;))